LEADS BIOLABS-B Shares Surge 6% in Afternoon Session on Potential Inclusion in Southbound Trading Scheme

Deep News15:00

LEADS BIOLABS-B (09887) saw its share price increase by 6% in the afternoon session, currently trading at HK$68.90, with a turnover of HK$30.7841 million.

Following the recent quarterly review results announced by Hang Seng Indexes Company, LEADS BIOLABS has been included in the Hang Seng Composite Index. All changes will take effect after the market close on March 6 and will be implemented starting March 9. A research report from CICC indicated that LEADS BIOLABS could potentially be added to the Southbound Stock Connect scheme in March. Meanwhile, Western Securities noted that, considering the company's multiple clinical data catalysts expected in 2026, a commercial inflection point is anticipated by 2027.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1199865714?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-23 15:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1199865714","market":"sh","top_or_hot":-1,"title":"LEADS BIOLABS-B Shares Surge 6% in Afternoon Session on Potential Inclusion in Southbound Trading Scheme","media":"Deep News","content":"<p>LEADS BIOLABS-B (09887) saw its share price increase by 6% in the afternoon session, currently trading at HK$68.90, with a turnover of HK$30.7841 million.</p>\n<p>Following the recent quarterly review results announced by Hang Seng Indexes Company, LEADS BIOLABS has been included in the Hang Seng Composite Index. All changes will take effect after the market close on March 6 and will be implemented starting March 9. A research report from CICC indicated that LEADS BIOLABS could potentially be added to the Southbound Stock Connect scheme in March. Meanwhile, Western Securities noted that, considering the company's multiple clinical data catalysts expected in 2026, a commercial inflection point is anticipated by 2027.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LEADS BIOLABS-B Shares Surge 6% in Afternoon Session on Potential Inclusion in Southbound Trading Scheme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLEADS BIOLABS-B Shares Surge 6% in Afternoon Session on Potential Inclusion in Southbound Trading Scheme\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-02-23 15:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LEADS BIOLABS-B (09887) saw its share price increase by 6% in the afternoon session, currently trading at HK$68.90, with a turnover of HK$30.7841 million.</p>\n<p>Following the recent quarterly review results announced by Hang Seng Indexes Company, LEADS BIOLABS has been included in the Hang Seng Composite Index. All changes will take effect after the market close on March 6 and will be implemented starting March 9. A research report from CICC indicated that LEADS BIOLABS could potentially be added to the Southbound Stock Connect scheme in March. Meanwhile, Western Securities noted that, considering the company's multiple clinical data catalysts expected in 2026, a commercial inflection point is anticipated by 2027.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VXUS","symbol_name":"国际股票ETF-Vanguard","start_time":0,"source_url":"","article_id":"1199865714","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1199865714","pubTimestamp":1771830019,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"LEADS BIOLABS-B (09887) saw its share price increase by 6% in the afternoon session, currently trading at HK$68.90, with a turnover of HK$30.7841 million. Following the recent quarterly review...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VXUS":"国际股票ETF-Vanguard","HK0000252160.HKD":"易方达 (香港) 中国股票股息基金A 类 (分派) 港元","VT":"世界全股市ETF-Vanguard","09887":"维立志博-B","BK4588":"碎股","HK0000500386.USD":"易方达 (香港) 中国股票股息基金A 类 (累积) 美元","BK1161":"生物科技","BK4585":"ETF&股票定投概念","HK0000252152.HKD":"易方达 (香港) 中国股票股息基金A 类 (累积) 港元"},"translate_title":"领先BIOLABS-B股价午后飙升6%，因可能纳入港股通交易计划","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VXUS":1,"VT":1,"09887":1},"content_text":"LEADS BIOLABS-B (09887) saw its share price increase by 6% in the afternoon session, currently trading at HK$68.90, with a turnover of HK$30.7841 million.\nFollowing the recent quarterly review results announced by Hang Seng Indexes Company, LEADS BIOLABS has been included in the Hang Seng Composite Index. All changes will take effect after the market close on March 6 and will be implemented starting March 9. A research report from CICC indicated that LEADS BIOLABS could potentially be added to the Southbound Stock Connect scheme in March. Meanwhile, Western Securities noted that, considering the company's multiple clinical data catalysts expected in 2026, a commercial inflection point is anticipated by 2027.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1199865714","isCrawlerRequest":true}